Drug maker Lupin launches Mirabegron extended-release tablets in US market

The Mumbai-based drug maker  Lupin has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement.

Drug maker Lupin launches Mirabegron extended-release tablets in US market
Lupin's product is a generic equivalent of Astellas Pharma Global Development, Inc's Myrbetriq extended-release tablets. Image: PTI

Drug maker Lupin on Monday said it has launched Mirabegron extended-release tablets (25 mg) in the US market.

The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement.

The company's product is a generic equivalent of Astellas Pharma Global Development, Inc's Myrbetriq extended-release tablets, it added.

Mirabegron extended-release tablets are used to treat certain bladder problems including overactive bladder.

Lupin shares were trading 3.38 per cent up at Rs 1,599.35 apiece on the BSE.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-how-soon-will-monthly-sip-of-rs-11000-reach-rs-8-crore-corpus-target-retirement-financial-planning-with-sip-calculator-334296

Power of Compounding: How soon will monthly SIP of Rs 11,000 reach Rs 8 crore corpus target?

https://www.zeebiz.com/market-news/news-short-term-investment-ideas-stocks-to-buy-for-15-days-axis-direct-recommends-fortis-healthcare-aegis-logistics-check-targets-334316

Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets

https://www.zeebiz.com/personal-finance/news-rs-1111-monthly-sip-for-40-yrs-11111-for-20-yrs-or-22222-for-10-years-which-works-best-at-same-expected-return-334395

Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?

https://www.zeebiz.com/personal-finance/photo-gallery-rs-3500-monthly-sip-for-35-years-vs-rs-35000-monthly-sip-for-16-years-which-can-give-you-higher-corpus-in-long-term-compound-interest-benefits-mutual-fund-return-calculator-retirement-planning-334249

Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations

https://www.zeebiz.com/personal-finance/photo-gallery-ppf-interest-rate-maturity-retirement-corpus-planning-calculator-how-to-get-inr-rs-72000-month-tax-free-income-from-public-provident-fund-calculations-80c-tax-benefits-333983

PPF Calculations: How to get Rs 72,000 a month tax-free income from Public Provident Fund?

Written By: PTI
Updated: Mon, Apr 22, 2024
12:35 PM IST
New Delhi, PTI
RELATED NEWS
Lupin gets 6 observations from USFDA for Pithampur plant Lupin gets 6 observations from USFDA for Pithampur plant
Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian market Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian market

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x